Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
Trump proposes allowing Medicare to base drug costs on prices abroad
President Donald Trump on Thursday announced two proposals reshaping how the government pays for drugs under Medicare Part B, including allowing Medicare to determine a drug’s price based on its cost in other countries, and altering the way physicians are reimbursed for prescribing treatments.
Experts offer strategies to address, combat burnout in clinical settings
ORLANDO, Fla. — A session presented at Psych Congress 2018 educated health care professionals about the risk for burnout in the health care setting, factors contributing to this risk, strategies for addressing burnout and tools for regular assessment to prevent burnout in the future.
Log in or Sign up for Free to view tailored content for your specialty!
FDA warns 465 websites selling unapproved opioids, drugs for cancer, HIV
The FDA sent warning letters this month to seven networks operating 465 websites that were selling potentially dangerous, unapproved versions of opioid, antiviral and oncology prescription drugs to U.S. consumers, according to a press release.
SLACK Incorporated Appoints Matt Holland Chief Commercial Officer
SLACK Incorporated, a Wyanoke Group Company, is pleased to announce Matthew J. Holland as Chief Commercial Officer. Holland will oversee print, digital and custom sales operations for Healio.com and all SLACK periodicals.
FDA committee approves AcelRx’s opioid formulation
By a 10-3 vote on Friday, the FDA’s Anesthetic and Analgesic Drug Products Advisory Committee said the benefits of AcelRx’s Dsuvia tablet outweigh the risks for managing moderate-to-severe acute pain in adults in medically-supervised settings.
FDA panel declines to recommend next generation IV opioid
The FDA’s Anesthetic and Analgesic Drug Products Advisory Committee voted 8-7 against recommending approval of IV oliceridine for the management of moderate to severe acute pain in adult patients who require an IV opioid in hospital and similar controlled clinical settings.
Trump administration says it's ending ACA ‘sabotage,’ experts say it comes at great risk to patients
The average premium for the second lowest cost silver health insurance plans — the one used to determine final premium tax credits — will drop by a “historical” 1.5% for the first-time since the implementation of the federally-facilitated Exchange in 2014, according to CMS.
Steps clinicians can take toward proper compensation
Several times throughout European history, the law set limits on what medical services patients could be billed for and some clinicians could not bill for services at all or sue to collect fees, lawyers Mark A. Hall and Carl E. Schneider wrote in the Journal of General Internal Medicine, who added that such laws were never enacted in the United States.
Dual VA, Medicare enrollment linked to overlapping opioid, benzodiazepine prescriptions
Receiving prescription medications from both VA and Medicare Part D was associated with a 27% higher risk for overlapping opioid and benzodiazepine prescriptions and a two times greater risk for overlapping high-dose opioids and benzodiazepines, according to findings published in Annals of Internal Medicine.
How to maximize face-to-face time with patients
The average time of a consultation in primary care rose from 15.56 minutes in 1993 to 21.07 minutes in 2012, research recently published in BMJ found.
-
Headline News
Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?
September 27, 20245 min read -
Headline News
Prenatal cannabis use in California nearly doubled amid legalization from 2012 to 2022
September 26, 20242 min read -
Headline News
'Encouraging': Antiviral ziresovir shows promise against RSV in infants
September 26, 20242 min read
-
Headline News
Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?
September 27, 20245 min read -
Headline News
Prenatal cannabis use in California nearly doubled amid legalization from 2012 to 2022
September 26, 20242 min read -
Headline News
'Encouraging': Antiviral ziresovir shows promise against RSV in infants
September 26, 20242 min read